AVEZANT

Welcome to the Brand page for “AVEZANT”, which is offered here for Human pharmaceuticals for the prevention or treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases and respiratory diseases; vaccines;.

Its status is currently believed to be active. Its class is unavailable. “AVEZANT” is believed to be currently owned by “Johnson & Johnson”.


Owner:
JOHNSON & JOHNSON
Owner Details
Description:
Human pharmaceuticals for the prevention or treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases and respiratory diseases; vaccines;
Categories: HUMAN PHARMACEUTICALS PREVENTION